Expression of cytokine genes in the aorta is altered by the deficiency in MCP-1: Effect of a high-fat, high-cholesterol diet

Cytokine

Volumn 50, Issue 2, 2010, Pages 121-128

  Rull, Anna ^a   Beltrán Debón, Raúl ^a   Aragonès, Gerard ^a   Rodríguez Sanabria, Fernando ^a   Alonso Villaverde, Carlos ^a   Camps, Jordi ^a   Joven, Jorge ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

Aortic gene profile; Atherosclerosis; Dietary fat and cholesterol; Hyperlipemic mice; MCP 1

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTERIOSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL DIET; CONTROLLED STUDY; GENE EXPRESSION; INTIMA; LIPID DIET; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTECTION; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STIMULUS RESPONSE;

MUS;

EID: 77950864475     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.02.010     Document Type: Article

References (44)

1. Ounpuu S., Anand S., Yusuf S. The impending global epidemic of cardiovascular diseases. Eur Heart J 2000, 21:880-883.
2. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126.
3. Glass C.K., Witztum J.L. Atherosclerosis. The road ahead. Cell 2001, 104:503-516.
4. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
5. Doevendans P.A., Jukema W., Spiering W., Defesche J.C., Kastelein J.J. Molecular genetics and gene expression in atherosclerosis. Int J Cardiol 2001, 80:161-172.
6. Andreassi M.G. Metabolic syndrome, diabetes and atherosclerosis: influence of gene-environment interaction. Mutat Res 2009, 667:35-43.
7. Roy H., Bhardwaj S., Yla-Herttuala S. Molecular genetics of atherosclerosis. Hum Genet 2009, 125:467-491.
8. Joven J., Rull A., Ferre N., Escola-Gil J.C., Marsillach J., Coll B., et al. The results in rodent models of atherosclerosis are not interchangeable: the influence of diet and strain. Atherosclerosis 2007, 195:e85-e92.
9. Daugherty A., Rateri D.L. Development of experimental designs for atherosclerosis studies in mice. Methods 2005, 36:129-138.
10. Kleemann R., Zadelaar S., Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 2008, 79:360-376.
11. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006, 86:515-581.
12. Cohen S. Cytokine: more than a new word, a new concept proposed by Stanley Cohen thirty years ago. Cytokine 2004, 28:242-247.
13. Gerard C., Rollins B.J. Chemokines and disease. Nat Immunol 2001, 2:108-115.
14. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006, 354:610-621.
15. Zernecke A., Shagdarsuren E., Weber C. Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol 2008, 28:1897-1908.
16. Gu L., Tseng S.C., Rollins B.J. Monocyte chemoattractant protein-1. Chem Immunol 1999, 72:7-29.
17. Aiello R.J., Bourassa P.A., Lindsey S., Weng W., Natoli E., Rollins B.J., et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 1999, 19:1518-1525.
18. van Royen N., Hoefer I., Buschmann I., Kostin S., Voskuil M., Bode C., et al. Effects of local MCP-1 protein therapy on the development of the collateral circulation and atherosclerosis in Watanabe hyperlipidemic rabbits. Cardiovasc Res 2003, 57:178-185.
19. Ni W., Kitamoto S., Ishibashi M., Usui M., Inoue S., Hiasa K., et al. Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 2004, 24:534-539.
20. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998, 2:275-281.
21. Gosling J., Slaymaker S., Gu L., Tseng S., Zlot C.H., Young S.G., et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 1999, 103:773-778.
22. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998, 394:894-897.
23. Tous M., Ferre N., Rull A., Marsillach J., Coll B., Alonso-Villaverde C., et al. Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochem Biophys Res Commun 2006, 340:1078-1084.
24. Rull A., Rodríguez F., Aragonès G., Marsillach J., Beltrán R., Alonso-Villaverde C., et al. Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis. Cytokine 2009, 48:273-279.
25. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006, 116:1494-1505.
26. Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006, 116:115-124.
27. Rull A., Escola-Gil J.C., Julve J., Rotllan N., Calpe-Berdiel L., Coll B., et al. Deficiency in monocyte chemoattractant protein-1 modifies lipid and glucose metabolism. Exp Mol Pathol 2007, 83:361-366.
28. Calleja L., Paris M.A., Paul A., Vilella E., Joven J., Jimenez A., et al. Low-cholesterol and high-fat diets reduce atherosclerotic lesion development in ApoE-knockout mice. Arterioscler Thromb Vasc Biol 1999, 19:2368-2375.
29. Akilesh S., Shaffer D.J., Roopenian D. Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis. Genome Res 2003, 13:1719-1727.
30. Al-Shahrour F., Minguez P., Vaquerizas J.M., Conde L., Dopazo J. BABELOMICS: a suite of web tools for functional annotation and analysis of groups of genes in high-throughput experiments. Nucleic Acids Res 2005, 33:W460-W464.
31. Herrero J., Al-Shahrour F., Díaz-Uriarte R., Mateos A., Vaquerizas J.M., Santoyo J., et al. GEPAS: a web-based resource for microarray gene expression data analysis. Nucleic Acids Res 2003, 31:3461-3467.
32. Kanehisa M., Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28:27-30.
33. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet 2000, 25:25-29.
34. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., et al. Cytoscape: a software environment for integrated models of bimolecular interaction network. Genome Res 2003, 13:2498-2504.
35. Haley K.J., Lilly C.M., Yang J.H., Feng Y., Kennedy S.P., Turi T.G., et al. Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 2000, 102:2185-2189.
36. Steppich B.A., Moog P., Matissek C., Wisniowski N., Kühle J., Joghetaei N., et al. Cytokine profiles and T cell function in acute coronary syndromes. Atherosclerosis 2007, 190:443-451.
37. Dulkys Y., Kluthe C., Buschermohle T., Barg I., Knoss S., Kapp A., et al. IL-3 induces down-regulation of CCR3 protein and mRNA in human eosinophils. J Immunol 2001, 167:3443-3453.
38. Schober A., Knarren S., Lietz M., Lin E.A., Weber C. Crucial role of stromal cell-derived factor-1α in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation 2003, 108:2491-2497.
39. Coll B., Parra S., Alonso-Villaverde C., Aragonés G., Montero M., Camps J., et al. The role of immunity and inflammation in the progression of atherosclerosis in patients with HIV infection. Stroke 2007, 38:2477-2484.
40. Jang M.K., Kim J.Y., Jeoung N.H., Kang M.A., Choi M.S., Oh G.T., et al. Oxidized low-density lipoproteins may induce expression of monocyte chemotactic protein-3 in atherosclerotic plaques. Biochem Biophys Res Commun 2004, 323:898-905.
41. Wang X., Li X., Yue T.L., Ohlstein E.H. Expression of monocyte chemotactic protein-3 mRNA in rat vascular smooth muscle cells and in carotid artery after balloon angioplasty. Biochim Biophys Acta 2000, 1500:41-48.
42. Sarafi M.N., Garcia-Zepeda E.A., MacLean J.A., Charo I.F., Luster A.D. Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. J Exp Med 1997, 185:99-109.
43. Jia T., Serbina N.V., Brandl K., Zhong M.X., Leiner I.M., Charo I.F., et al. Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection. J Immunol 2008, 180:6846-6853.
44. Beltrán-Debón R., Alonso-Villaverde C., Aragonès G., Rodríguez-Medina I., Rull A., Micol V., et al. The aqueous extract of Hibiscus sabdariffa calices modulates the production of monocyte chemoattractant protein-1 in humans. Phytomedicine 2010, 17:186-191.